Long-term outcomes of bronchopulmonary dysplasia

Lex W Doyle1, Peter J Anderson

  • 1Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia.

Insights

More very preterm infants survive with bronchopulmonary dysplasia (BPD), leading to long-term cognitive, educational, behavioral, and respiratory issues. Further research is needed to understand the lifelong impact of these BPD-related problems into adulthood.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Developmental Pediatrics

Background:

  • Increasing survival rates of very preterm infants.
  • Bronchopulmonary dysplasia (BPD) is a common complication in these infants.
  • BPD is associated with significant neurodevelopmental and respiratory morbidities in childhood.

Purpose of the Study:

  • To highlight the growing prevalence of bronchopulmonary dysplasia (BPD) in surviving very preterm infants.
  • To underscore the known childhood neurodevelopmental and respiratory impairments associated with BPD.
  • To emphasize the need for longitudinal studies determining the lifelong impact of BPD into adulthood.

Main Methods:

  • This study is a review and synthesis of existing literature on BPD outcomes.
  • Analysis of long-term follow-up data for individuals with a history of BPD.
  • Identification of research gaps regarding adult outcomes.

Main Results:

  • The survival of very preterm infants is increasing, leading to a higher incidence of BPD.
  • Children with BPD exhibit elevated rates of cognitive, educational, and behavioral impairments.
  • Reduced lung function is a persistent issue for BPD survivors throughout childhood and into early adult life.

Conclusions:

  • Bronchopulmonary dysplasia (BPD) presents a growing challenge with significant, lasting consequences for survivors.
  • The long-term neurological and respiratory sequelae of BPD require comprehensive investigation into adult life.
  • Further research is crucial to fully understand and manage the lifelong health burden of BPD.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...